Bleomycin toxcity is characterized by destructionof aEUR’
**Core Concept**
Bleomycin toxicity is a well-documented side effect of the chemotherapeutic agent bleomycin, which is used to treat various types of cancer. The toxicity is primarily related to the drug's ability to cause damage to lung tissue, leading to a condition known as pulmonary fibrosis. This occurs due to the generation of reactive oxygen species (ROS) that damage the alveolar epithelial cells.
**Why the Correct Answer is Right**
Bleomycin works by binding to DNA and causing strand scission, which leads to the generation of ROS. These ROS then cause oxidative stress, leading to the activation of various cell death pathways, including apoptosis and necrosis. The primary site of bleomycin toxicity is the lung, where the drug is metabolized to its active form, bleomycin A2. This active form then binds to DNA, leading to the formation of free radicals that cause damage to the lung tissue.
**Why Each Wrong Option is Incorrect**
* **Option A:** While bleomycin does cause damage to lung tissue, it is not primarily associated with the destruction of the bronchi. The bronchi are involved in the airway, whereas the primary site of bleomycin toxicity is the alveoli.
* **Option B:** Bleomycin toxicity is not primarily associated with the destruction of the myocardium. While the drug can cause cardiotoxicity, this is not its primary mechanism of action.
* **Option C:** Bleomycin toxicity is not primarily associated with the destruction of the gastrointestinal tract. While the drug can cause mucositis and other gastrointestinal side effects, this is not its primary mechanism of action.
**Clinical Pearl / High-Yield Fact**
Bleomycin toxicity is a dose-dependent side effect, and the risk of pulmonary fibrosis increases with cumulative dose. Therefore, it is essential to monitor lung function and perform regular pulmonary function tests (PFTs) in patients receiving bleomycin therapy.
**Correct Answer:** D.